

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.69247533 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.69247533 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.69247533 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.69247533 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.69247533 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.69247533 |
| 7 | negative regulation of cell killing (GO:0031342) | 6.63699478 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.63699478 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.53544616 |
| 10 | detection of other organism (GO:0098543) | 5.49651009 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.49014896 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.29326739 |
| 13 | detection of bacterium (GO:0016045) | 5.17063313 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 5.12599196 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 5.03718435 |
| 16 | respiratory burst (GO:0045730) | 4.95103858 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 4.93712690 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.88840694 |
| 19 | response to peptidoglycan (GO:0032494) | 4.85631330 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.83795040 |
| 21 | leukocyte aggregation (GO:0070486) | 4.78136564 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75777497 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.58218345 |
| 24 | cellular extravasation (GO:0045123) | 4.52822834 |
| 25 | response to host immune response (GO:0052572) | 4.47198075 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.47198075 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.45396726 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.40812113 |
| 29 | neutrophil activation (GO:0042119) | 4.39028409 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.35591507 |
| 31 | detection of biotic stimulus (GO:0009595) | 4.24642165 |
| 32 | viral transcription (GO:0019083) | 4.21596997 |
| 33 | response to interleukin-15 (GO:0070672) | 4.17831775 |
| 34 | DNA deamination (GO:0045006) | 4.16778403 |
| 35 | doxorubicin metabolic process (GO:0044598) | 4.15314394 |
| 36 | daunorubicin metabolic process (GO:0044597) | 4.15314394 |
| 37 | polyketide metabolic process (GO:0030638) | 4.15314394 |
| 38 | microglial cell activation (GO:0001774) | 4.13290732 |
| 39 | response to host (GO:0075136) | 4.05765791 |
| 40 | response to host defenses (GO:0052200) | 4.05765791 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.05765791 |
| 42 | translational termination (GO:0006415) | 4.04804326 |
| 43 | neutrophil mediated immunity (GO:0002446) | 4.00445613 |
| 44 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.95232828 |
| 45 | granulocyte activation (GO:0036230) | 3.94595919 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.84563620 |
| 47 | macrophage activation (GO:0042116) | 3.82370578 |
| 48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.81578896 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 3.81376146 |
| 50 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.80251303 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.75401692 |
| 52 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.74065957 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.72908880 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.71102072 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.67360482 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.65408894 |
| 57 | DNA strand elongation (GO:0022616) | 3.62527192 |
| 58 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.57718017 |
| 59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.57499716 |
| 60 | translational elongation (GO:0006414) | 3.52627835 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51712013 |
| 62 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.50010746 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.48944030 |
| 64 | ribosomal small subunit biogenesis (GO:0042274) | 3.47936052 |
| 65 | interferon-gamma production (GO:0032609) | 3.45470685 |
| 66 | myeloid leukocyte mediated immunity (GO:0002444) | 3.40855979 |
| 67 | telomere maintenance via recombination (GO:0000722) | 3.40045760 |
| 68 | mitotic sister chromatid cohesion (GO:0007064) | 3.37549442 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.36195780 |
| 70 | V(D)J recombination (GO:0033151) | 3.35391728 |
| 71 | maturation of SSU-rRNA (GO:0030490) | 3.35188440 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 3.34552647 |
| 73 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.32801432 |
| 74 | negative regulation of phagocytosis (GO:0050765) | 3.29871305 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.29339575 |
| 76 | DNA replication initiation (GO:0006270) | 3.28103057 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.27583564 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.27583564 |
| 79 | translesion synthesis (GO:0019985) | 3.25456756 |
| 80 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.25142906 |
| 81 | response to type I interferon (GO:0034340) | 3.24639799 |
| 82 | leukocyte degranulation (GO:0043299) | 3.23562421 |
| 83 | cotranslational protein targeting to membrane (GO:0006613) | 3.21818607 |
| 84 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.21576438 |
| 85 | regulation of regulated secretory pathway (GO:1903305) | 3.21544501 |
| 86 | protein targeting to ER (GO:0045047) | 3.21262431 |
| 87 | DNA unwinding involved in DNA replication (GO:0006268) | 3.17706858 |
| 88 | cellular protein complex disassembly (GO:0043624) | 3.16777821 |
| 89 | regulation of histone H3-K9 methylation (GO:0051570) | 3.15292198 |
| 90 | regulation of B cell differentiation (GO:0045577) | 3.14843612 |
| 91 | mitotic recombination (GO:0006312) | 3.14337883 |
| 92 | protein localization to chromosome, centromeric region (GO:0071459) | 3.13928499 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13809578 |
| 94 | viral life cycle (GO:0019058) | 3.12321656 |
| 95 | B cell mediated immunity (GO:0019724) | 3.10750574 |
| 96 | translational initiation (GO:0006413) | 3.10071784 |
| 97 | dendritic cell chemotaxis (GO:0002407) | 3.09543739 |
| 98 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08627891 |
| 99 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.08325233 |
| 100 | dendritic cell migration (GO:0036336) | 3.07535294 |
| 101 | negative regulation of RNA splicing (GO:0033119) | 3.07013345 |
| 102 | regulation of T cell tolerance induction (GO:0002664) | 3.05004084 |
| 103 | regulation of mast cell activation (GO:0033003) | 3.04916268 |
| 104 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04580740 |
| 105 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04466005 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04307113 |
| 107 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03136309 |
| 108 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.02331459 |
| 109 | regulation of tolerance induction (GO:0002643) | 3.00526075 |
| 110 | protein localization to endoplasmic reticulum (GO:0070972) | 2.99407671 |
| 111 | T cell homeostasis (GO:0043029) | 2.97603100 |
| 112 | negative regulation of innate immune response (GO:0045824) | 2.97450452 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.97273192 |
| 114 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96686976 |
| 115 | protein complex disassembly (GO:0043241) | 2.95553123 |
| 116 | defense response to protozoan (GO:0042832) | 2.95043248 |
| 117 | telomere maintenance via telomere lengthening (GO:0010833) | 2.94066452 |
| 118 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.92252351 |
| 119 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92120078 |
| 120 | ribosomal large subunit biogenesis (GO:0042273) | 2.90322014 |
| 121 | positive regulation of interferon-alpha production (GO:0032727) | 2.89984981 |
| 122 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.88807054 |
| 123 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88464181 |
| 124 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88464181 |
| 125 | protein localization to kinetochore (GO:0034501) | 2.88353832 |
| 126 | dosage compensation (GO:0007549) | 2.87040395 |
| 127 | negative regulation of interleukin-6 production (GO:0032715) | 2.85375214 |
| 128 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85163881 |
| 129 | definitive hemopoiesis (GO:0060216) | 2.84517025 |
| 130 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.84256197 |
| 131 | positive regulation of regulated secretory pathway (GO:1903307) | 2.83819650 |
| 132 | negative regulation of type 2 immune response (GO:0002829) | 2.82799478 |
| 133 | myeloid leukocyte activation (GO:0002274) | 2.81930239 |
| 134 | motile cilium assembly (GO:0044458) | 2.81919973 |
| 135 | chromatin remodeling at centromere (GO:0031055) | 2.80806642 |
| 136 | interferon-gamma secretion (GO:0072643) | 2.80456763 |
| 137 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80037254 |
| 138 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.79266387 |
| 139 | germinal center formation (GO:0002467) | 2.78288604 |
| 140 | mRNA catabolic process (GO:0006402) | 2.78058558 |
| 141 | neutrophil chemotaxis (GO:0030593) | 2.77163100 |
| 142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76196708 |
| 143 | intra-S DNA damage checkpoint (GO:0031573) | 2.76190881 |
| 144 | CENP-A containing nucleosome assembly (GO:0034080) | 2.74531438 |
| 145 | regulation of erythrocyte differentiation (GO:0045646) | 2.74295274 |
| 146 | RNA catabolic process (GO:0006401) | 2.73387247 |
| 147 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.73243827 |
| 148 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.71653778 |
| 149 | macromolecular complex disassembly (GO:0032984) | 2.71428636 |
| 150 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.71250903 |
| 151 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70573173 |
| 152 | embryonic hemopoiesis (GO:0035162) | 2.70567945 |
| 153 | positive regulation of granulocyte differentiation (GO:0030854) | 2.70519299 |
| 154 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70133861 |
| 155 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70133861 |
| 156 | DNA replication checkpoint (GO:0000076) | 2.67478116 |
| 157 | centriole assembly (GO:0098534) | 2.65504692 |
| 158 | DNA replication-independent nucleosome organization (GO:0034724) | 2.64818221 |
| 159 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.64818221 |
| 160 | DNA topological change (GO:0006265) | 2.63857590 |
| 161 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.63237696 |
| 162 | positive regulation of B cell differentiation (GO:0045579) | 2.63206828 |
| 163 | regulation of DNA endoreduplication (GO:0032875) | 2.63164054 |
| 164 | granulocyte differentiation (GO:0030851) | 2.62359049 |
| 165 | kinetochore organization (GO:0051383) | 2.62349691 |
| 166 | erythrocyte maturation (GO:0043249) | 2.61460955 |
| 167 | telomere organization (GO:0032200) | 2.60344614 |
| 168 | somatic cell DNA recombination (GO:0016444) | 2.60059182 |
| 169 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.60059182 |
| 170 | telomere maintenance (GO:0000723) | 2.59863076 |
| 171 | positive T cell selection (GO:0043368) | 2.57122238 |
| 172 | DNA synthesis involved in DNA repair (GO:0000731) | 2.56011951 |
| 173 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.55949682 |
| 174 | histone H2A acetylation (GO:0043968) | 2.55712993 |
| 175 | termination of RNA polymerase II transcription (GO:0006369) | 2.55697703 |
| 176 | negative regulation of mRNA processing (GO:0050686) | 2.54355762 |
| 177 | positive thymic T cell selection (GO:0045059) | 2.53906743 |
| 178 | tRNA methylation (GO:0030488) | 2.49923726 |
| 179 | megakaryocyte development (GO:0035855) | 2.49755010 |
| 180 | somatic diversification of immune receptors (GO:0002200) | 2.48887613 |
| 181 | lymphoid progenitor cell differentiation (GO:0002320) | 2.47949139 |
| 182 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.47789721 |
| 183 | histone exchange (GO:0043486) | 2.43432808 |
| 184 | lymphocyte homeostasis (GO:0002260) | 2.42888876 |
| 185 | histone mRNA metabolic process (GO:0008334) | 2.42179112 |
| 186 | kinetochore assembly (GO:0051382) | 2.40680726 |
| 187 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.38193547 |
| 188 | protein localization to chromosome (GO:0034502) | 2.37140619 |
| 189 | pseudouridine synthesis (GO:0001522) | 2.36955382 |
| 190 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.36845412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.53516712 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.88251818 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.62028132 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35389068 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.01208372 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.00836656 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96300213 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.94887201 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.91609009 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83059000 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.57957344 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.56962244 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.56126895 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53299728 |
| 15 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46675382 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35437995 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33868339 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33057945 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.27978131 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23538724 |
| 21 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.22516079 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20884449 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.13357562 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13172376 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07931282 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.02854718 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01377342 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99340869 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96728237 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95256137 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95200171 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93753477 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93380722 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92617624 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92054957 |
| 36 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.91627337 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90867560 |
| 38 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.88086797 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.86515327 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.85957945 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.85767889 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84860861 |
| 43 | * MYB_26560356_Chip-Seq_TH2_Human | 1.84692937 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.84373918 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78552784 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77058306 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73194519 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.69647599 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69567480 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.69123885 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.67840531 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.65869889 |
| 53 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.65265004 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62564621 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.62416973 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61748612 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60279607 |
| 58 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.59565918 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.59207323 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58478518 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.57903722 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57718330 |
| 63 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55928918 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55610379 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54126519 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52410357 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52052721 |
| 68 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.51628539 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51372601 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.49082736 |
| 71 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45090941 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43058934 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41910274 |
| 74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39888722 |
| 75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39569069 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.39310164 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37531232 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36649131 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.35668037 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35410982 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34596952 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33032594 |
| 83 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32526693 |
| 84 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32286411 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30503752 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30140814 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29371940 |
| 88 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.28816959 |
| 89 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.28816959 |
| 90 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.28816959 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.28623103 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28083524 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26026555 |
| 94 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25990222 |
| 95 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.25385788 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25217179 |
| 97 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.24992209 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24831614 |
| 99 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24642699 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22345308 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21866980 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.21776369 |
| 103 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21447463 |
| 104 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.21424819 |
| 105 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21251584 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21153717 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20421208 |
| 108 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20291943 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19773742 |
| 110 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19689858 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18740441 |
| 112 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18479282 |
| 113 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18298119 |
| 114 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16470061 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16057688 |
| 116 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14805959 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14601354 |
| 118 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11868765 |
| 119 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09565775 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07948078 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07249155 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07131101 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06554723 |
| 124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05443792 |
| 125 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05205290 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04340791 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03999145 |
| 128 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03398181 |
| 129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00416005 |
| 130 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00317312 |
| 131 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00021531 |
| 132 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99167587 |
| 133 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98417820 |
| 134 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97191132 |
| 135 | P68_20966046_ChIP-Seq_HELA_Human | 0.96434520 |
| 136 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96176041 |
| 137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95842576 |
| 138 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95268113 |
| 139 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94427707 |
| 140 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94183209 |
| 141 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94012779 |
| 142 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93843140 |
| 143 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93772600 |
| 144 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93507570 |
| 145 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93372965 |
| 146 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93313150 |
| 147 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92552618 |
| 148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90671703 |
| 149 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89919614 |
| 150 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87298049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.75276749 |
| 2 | MP0008057_abnormal_DNA_replication | 3.66696244 |
| 3 | MP0008260_abnormal_autophagy | 3.25679811 |
| 4 | MP0002132_abnormal_respiratory_system | 3.09103668 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.04258786 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.98378369 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.91388397 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.83953789 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.82097663 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.82097663 |
| 11 | MP0004808_abnormal_hematopoietic_stem | 2.60426267 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.58511146 |
| 13 | MP0000490_abnormal_crypts_of | 2.57579764 |
| 14 | MP0008058_abnormal_DNA_repair | 2.44936565 |
| 15 | MP0003077_abnormal_cell_cycle | 2.44644414 |
| 16 | MP0005451_abnormal_body_composition | 2.30816905 |
| 17 | MP0002398_abnormal_bone_marrow | 2.19786135 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.08658958 |
| 19 | MP0006082_CNS_inflammation | 2.06458792 |
| 20 | MP0000703_abnormal_thymus_morphology | 2.05523670 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.98472798 |
| 22 | MP0000685_abnormal_immune_system | 1.94230747 |
| 23 | MP0005174_abnormal_tail_pigmentation | 1.92668028 |
| 24 | MP0008007_abnormal_cellular_replicative | 1.90663451 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.90637793 |
| 26 | MP0005671_abnormal_response_to | 1.84089191 |
| 27 | MP0003828_pulmonary_edema | 1.83517074 |
| 28 | MP0009278_abnormal_bone_marrow | 1.81798289 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.78877633 |
| 30 | MP0002722_abnormal_immune_system | 1.77110633 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.76966962 |
| 32 | MP0001873_stomach_inflammation | 1.76754289 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.75533239 |
| 34 | MP0001800_abnormal_humoral_immune | 1.70245698 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.70123109 |
| 36 | MP0000716_abnormal_immune_system | 1.69694122 |
| 37 | MP0001819_abnormal_immune_cell | 1.67582192 |
| 38 | MP0004381_abnormal_hair_follicle | 1.63596125 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.61861251 |
| 40 | MP0002006_tumorigenesis | 1.61544919 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.60728331 |
| 42 | MP0003436_decreased_susceptibility_to | 1.60005659 |
| 43 | MP0002429_abnormal_blood_cell | 1.58901333 |
| 44 | MP0002723_abnormal_immune_serum | 1.56725937 |
| 45 | MP0002405_respiratory_system_inflammati | 1.56710528 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.54029898 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.53408521 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.52845496 |
| 49 | MP0005410_abnormal_fertilization | 1.51605835 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.51277292 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.49909160 |
| 52 | MP0003866_abnormal_defecation | 1.46724341 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.46625030 |
| 54 | MP0005025_abnormal_response_to | 1.46239502 |
| 55 | MP0002009_preneoplasia | 1.44096541 |
| 56 | MP0001853_heart_inflammation | 1.42413844 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.41224348 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.39846453 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.38083065 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.36206877 |
| 61 | MP0003724_increased_susceptibility_to | 1.32006811 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.31071577 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.30753199 |
| 64 | MP0009785_altered_susceptibility_to | 1.28570618 |
| 65 | MP0008469_abnormal_protein_level | 1.28411181 |
| 66 | MP0008995_early_reproductive_senescence | 1.26824963 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.21549217 |
| 68 | MP0001790_abnormal_immune_system | 1.20311537 |
| 69 | MP0005387_immune_system_phenotype | 1.20311537 |
| 70 | MP0003786_premature_aging | 1.20243460 |
| 71 | MP0009764_decreased_sensitivity_to | 1.19264767 |
| 72 | MP0002419_abnormal_innate_immunity | 1.18499763 |
| 73 | MP0000313_abnormal_cell_death | 1.18328659 |
| 74 | MP0004883_abnormal_blood_vessel | 1.18270753 |
| 75 | MP0000350_abnormal_cell_proliferation | 1.17609106 |
| 76 | MP0001929_abnormal_gametogenesis | 1.17299812 |
| 77 | MP0000858_altered_metastatic_potential | 1.15826905 |
| 78 | MP0001851_eye_inflammation | 1.14141883 |
| 79 | MP0004147_increased_porphyrin_level | 1.11010818 |
| 80 | MP0010307_abnormal_tumor_latency | 1.10659771 |
| 81 | MP0002163_abnormal_gland_morphology | 1.08873259 |
| 82 | MP0000015_abnormal_ear_pigmentation | 1.08709642 |
| 83 | MP0001986_abnormal_taste_sensitivity | 1.08464417 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 1.07869927 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.06065499 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 1.03830836 |
| 87 | MP0002210_abnormal_sex_determination | 1.03664455 |
| 88 | MP0003075_altered_response_to | 1.03049801 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94891819 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 0.92325284 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.91895583 |
| 92 | MP0003303_peritoneal_inflammation | 0.91077571 |
| 93 | MP0005409_darkened_coat_color | 0.90796432 |
| 94 | MP0003787_abnormal_imprinting | 0.90790485 |
| 95 | MP0003698_abnormal_male_reproductive | 0.90470713 |
| 96 | MP0005058_abnormal_lysosome_morphology | 0.89336547 |
| 97 | MP0001663_abnormal_digestive_system | 0.89294612 |
| 98 | MP0003878_abnormal_ear_physiology | 0.88956760 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.88956760 |
| 100 | MP0002254_reproductive_system_inflammat | 0.88885707 |
| 101 | MP0003806_abnormal_nucleotide_metabolis | 0.88568316 |
| 102 | MP0005083_abnormal_biliary_tract | 0.88349891 |
| 103 | MP0001145_abnormal_male_reproductive | 0.86301974 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.84912720 |
| 105 | MP0003690_abnormal_glial_cell | 0.83393752 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.83212738 |
| 107 | MP0004264_abnormal_extraembryonic_tissu | 0.82484541 |
| 108 | MP0004858_abnormal_nervous_system | 0.82257380 |
| 109 | MP0003448_altered_tumor_morphology | 0.81028868 |
| 110 | MP0005310_abnormal_salivary_gland | 0.79551281 |
| 111 | MP0008004_abnormal_stomach_pH | 0.79453458 |
| 112 | MP0001188_hyperpigmentation | 0.79318073 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.78348836 |
| 114 | MP0004947_skin_inflammation | 0.78147662 |
| 115 | MP0006054_spinal_hemorrhage | 0.77952189 |
| 116 | MP0000653_abnormal_sex_gland | 0.77807531 |
| 117 | MP0005164_abnormal_response_to | 0.76748041 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.74357303 |
| 119 | MP0005166_decreased_susceptibility_to | 0.74334220 |
| 120 | MP0001730_embryonic_growth_arrest | 0.72691112 |
| 121 | MP0005390_skeleton_phenotype | 0.71695135 |
| 122 | MP0002102_abnormal_ear_morphology | 0.71052823 |
| 123 | MP0004510_myositis | 0.70735623 |
| 124 | MP0008932_abnormal_embryonic_tissue | 0.70243661 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.67589169 |
| 126 | MP0009763_increased_sensitivity_to | 0.66319685 |
| 127 | MP0001849_ear_inflammation | 0.66212936 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.65204873 |
| 129 | MP0005423_abnormal_somatic_nervous | 0.64662171 |
| 130 | MP0001293_anophthalmia | 0.62524469 |
| 131 | MP0000470_abnormal_stomach_morphology | 0.62242062 |
| 132 | MP0002080_prenatal_lethality | 0.60405479 |
| 133 | MP0009697_abnormal_copulation | 0.59900064 |
| 134 | MP0008874_decreased_physiological_sensi | 0.59599098 |
| 135 | MP0001119_abnormal_female_reproductive | 0.59285663 |
| 136 | MP0005394_taste/olfaction_phenotype | 0.59242815 |
| 137 | MP0003705_abnormal_hypodermis_morpholog | 0.56803785 |
| 138 | MP0002796_impaired_skin_barrier | 0.56335702 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.55502310 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.52446852 |
| 141 | MP0003795_abnormal_bone_structure | 0.51515163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 5.53027364 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.32754672 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.12990980 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.96863465 |
| 5 | Stomatitis (HP:0010280) | 4.96294847 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 4.92486403 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 4.51006556 |
| 8 | Chronic otitis media (HP:0000389) | 4.35790459 |
| 9 | Hypochromic anemia (HP:0001931) | 4.16161425 |
| 10 | Recurrent skin infections (HP:0001581) | 4.06421430 |
| 11 | Reticulocytopenia (HP:0001896) | 3.89415256 |
| 12 | Gingivitis (HP:0000230) | 3.85736779 |
| 13 | Urticaria (HP:0001025) | 3.75662387 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.74966582 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.52801903 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.49905712 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.46102079 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.45177909 |
| 19 | Increased IgE level (HP:0003212) | 3.42469475 |
| 20 | Petechiae (HP:0000967) | 3.31626681 |
| 21 | Chromsome breakage (HP:0040012) | 3.26956014 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.22837516 |
| 23 | Thrombocytosis (HP:0001894) | 3.16482707 |
| 24 | Vasculitis (HP:0002633) | 3.15621249 |
| 25 | Abnormality of B cell number (HP:0010975) | 3.14964866 |
| 26 | B lymphocytopenia (HP:0010976) | 3.14964866 |
| 27 | Chest pain (HP:0100749) | 3.12482457 |
| 28 | Anorexia (HP:0002039) | 3.10240173 |
| 29 | Pallor (HP:0000980) | 3.05366043 |
| 30 | Absent/shortened dynein arms (HP:0200106) | 2.97526525 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.97526525 |
| 32 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.97366644 |
| 33 | Episodic fever (HP:0001954) | 2.93448394 |
| 34 | Prolonged bleeding time (HP:0003010) | 2.93276407 |
| 35 | Nasal polyposis (HP:0100582) | 2.91273326 |
| 36 | Myositis (HP:0100614) | 2.90306445 |
| 37 | Arterial thrombosis (HP:0004420) | 2.88804333 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.88024687 |
| 39 | Microcytic anemia (HP:0001935) | 2.86329252 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.86231612 |
| 41 | IgM deficiency (HP:0002850) | 2.84729059 |
| 42 | Aplastic anemia (HP:0001915) | 2.83315975 |
| 43 | Recurrent viral infections (HP:0004429) | 2.80868093 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76534477 |
| 45 | Acute lymphatic leukemia (HP:0006721) | 2.74305581 |
| 46 | Hemoptysis (HP:0002105) | 2.73877057 |
| 47 | Peritonitis (HP:0002586) | 2.71121416 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.70541352 |
| 49 | Myelodysplasia (HP:0002863) | 2.69181279 |
| 50 | Osteomyelitis (HP:0002754) | 2.69018841 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.66216368 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.63587475 |
| 53 | Gingival bleeding (HP:0000225) | 2.63270793 |
| 54 | Birth length less than 3rd percentile (HP:0003561) | 2.61659648 |
| 55 | Abnormality of the preputium (HP:0100587) | 2.61039970 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.59142873 |
| 57 | Volvulus (HP:0002580) | 2.56875923 |
| 58 | Metaphyseal cupping (HP:0003021) | 2.55479486 |
| 59 | Pulmonary embolism (HP:0002204) | 2.54584518 |
| 60 | Increased IgM level (HP:0003496) | 2.53210474 |
| 61 | Acute myeloid leukemia (HP:0004808) | 2.49139442 |
| 62 | Abnormality of chromosome stability (HP:0003220) | 2.46941296 |
| 63 | Abnormality of DNA repair (HP:0003254) | 2.46442067 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.41269300 |
| 65 | T lymphocytopenia (HP:0005403) | 2.40616922 |
| 66 | Amyloidosis (HP:0011034) | 2.39674747 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.38735367 |
| 68 | Cheilitis (HP:0100825) | 2.36218288 |
| 69 | Optic neuritis (HP:0100653) | 2.35936467 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.35936467 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.35737437 |
| 72 | Sepsis (HP:0100806) | 2.34932591 |
| 73 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.34667478 |
| 74 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.34667478 |
| 75 | Meningitis (HP:0001287) | 2.34274548 |
| 76 | Poikiloderma (HP:0001029) | 2.34112627 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.33440638 |
| 78 | Type I transferrin isoform profile (HP:0003642) | 2.32726587 |
| 79 | Thyroiditis (HP:0100646) | 2.32504071 |
| 80 | Slow saccadic eye movements (HP:0000514) | 2.31650173 |
| 81 | Abnormality of T cells (HP:0002843) | 2.30902060 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30263745 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30263745 |
| 84 | Macrocytic anemia (HP:0001972) | 2.29716679 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.29385961 |
| 86 | Prominent nose (HP:0000448) | 2.28120383 |
| 87 | Abnormality of T cell number (HP:0011839) | 2.27345771 |
| 88 | Granulocytopenia (HP:0001913) | 2.26841478 |
| 89 | Eosinophilia (HP:0001880) | 2.25866603 |
| 90 | Lymphoma (HP:0002665) | 2.23635411 |
| 91 | Abnormality of the columella (HP:0009929) | 2.22700548 |
| 92 | Prostate neoplasm (HP:0100787) | 2.21908437 |
| 93 | IgG deficiency (HP:0004315) | 2.19573198 |
| 94 | Abnormality of the nasal mucosa (HP:0000433) | 2.19439017 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 2.19317431 |
| 96 | Clubbing of toes (HP:0100760) | 2.17029832 |
| 97 | Acanthocytosis (HP:0001927) | 2.16211333 |
| 98 | Chronic sinusitis (HP:0011109) | 2.14948267 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.13436534 |
| 100 | Recurrent bronchitis (HP:0002837) | 2.12196664 |
| 101 | Increased serum ferritin (HP:0003281) | 2.12115340 |
| 102 | Gangrene (HP:0100758) | 2.11452769 |
| 103 | Ectopic kidney (HP:0000086) | 2.10836711 |
| 104 | Pustule (HP:0200039) | 2.09491622 |
| 105 | Absent thumb (HP:0009777) | 2.09095876 |
| 106 | Skin ulcer (HP:0200042) | 2.08421210 |
| 107 | Abnormality of the ileum (HP:0001549) | 2.06581051 |
| 108 | Recurrent abscess formation (HP:0002722) | 2.06096235 |
| 109 | Poikilocytosis (HP:0004447) | 2.05047618 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04409237 |
| 111 | Meckel diverticulum (HP:0002245) | 2.04235024 |
| 112 | Abnormality of T cell physiology (HP:0011840) | 2.03894762 |
| 113 | Viral hepatitis (HP:0006562) | 2.03468342 |
| 114 | Abnormality of eosinophils (HP:0001879) | 2.03290538 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03211837 |
| 116 | Obstructive lung disease (HP:0006536) | 2.03211837 |
| 117 | Abnormal number of incisors (HP:0011064) | 2.03150436 |
| 118 | Colitis (HP:0002583) | 2.02784160 |
| 119 | Abnormality of the pleura (HP:0002103) | 2.02732035 |
| 120 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.02223054 |
| 121 | Optic nerve coloboma (HP:0000588) | 2.01300705 |
| 122 | Abnormality of the endocardium (HP:0004306) | 2.01181474 |
| 123 | Hepatosplenomegaly (HP:0001433) | 2.01162093 |
| 124 | Combined immunodeficiency (HP:0005387) | 1.99836477 |
| 125 | Eczematoid dermatitis (HP:0000976) | 1.98383899 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 1.98258584 |
| 127 | Bone marrow hypocellularity (HP:0005528) | 1.97408459 |
| 128 | Orchitis (HP:0100796) | 1.97286738 |
| 129 | Acute hepatic failure (HP:0006554) | 1.97067461 |
| 130 | Glomerulopathy (HP:0100820) | 1.93303053 |
| 131 | Recurrent bacterial skin infections (HP:0005406) | 1.93119642 |
| 132 | Muscle fiber atrophy (HP:0100295) | 1.91934475 |
| 133 | Hypermelanotic macule (HP:0001034) | 1.91287487 |
| 134 | Encephalitis (HP:0002383) | 1.89666704 |
| 135 | Abnormality of reticulocytes (HP:0004312) | 1.89502866 |
| 136 | Toxemia of pregnancy (HP:0100603) | 1.88166550 |
| 137 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87762967 |
| 138 | Acne (HP:0001061) | 1.87626083 |
| 139 | Bronchiectasis (HP:0002110) | 1.87581651 |
| 140 | Epistaxis (HP:0000421) | 1.86240250 |
| 141 | Oral leukoplakia (HP:0002745) | 1.85476734 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84566883 |
| 143 | Abnormal platelet function (HP:0011869) | 1.83979322 |
| 144 | Impaired platelet aggregation (HP:0003540) | 1.83979322 |
| 145 | Leukocytosis (HP:0001974) | 1.83508597 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 1.82341583 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.82310361 |
| 148 | Amaurosis fugax (HP:0100576) | 1.81917480 |
| 149 | Abnormality of the pericardium (HP:0001697) | 1.81780245 |
| 150 | Cellulitis (HP:0100658) | 1.81276592 |
| 151 | Keratitis (HP:0000491) | 1.81152591 |
| 152 | Abnormal platelet volume (HP:0011876) | 1.80984983 |
| 153 | Exertional dyspnea (HP:0002875) | 1.80270898 |
| 154 | Recurrent pneumonia (HP:0006532) | 1.80015456 |
| 155 | Polycythemia (HP:0001901) | 1.79709427 |
| 156 | Lymphopenia (HP:0001888) | 1.79521359 |
| 157 | Purpura (HP:0000979) | 1.78712881 |
| 158 | Pancytopenia (HP:0001876) | 1.78690423 |
| 159 | Increased cerebral lipofuscin (HP:0011813) | 1.77269424 |
| 160 | Difficulty running (HP:0009046) | 1.76990135 |
| 161 | Thrombophlebitis (HP:0004418) | 1.76120902 |
| 162 | Vertigo (HP:0002321) | 1.75028258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.81281873 |
| 2 | MAP4K1 | 3.29454961 |
| 3 | CDC7 | 2.90733008 |
| 4 | ERN1 | 2.84055647 |
| 5 | CSK | 2.73052415 |
| 6 | SIK3 | 2.70108861 |
| 7 | TXK | 2.69391732 |
| 8 | EEF2K | 2.61763685 |
| 9 | FES | 2.61714078 |
| 10 | MAP3K10 | 2.51973092 |
| 11 | NEK2 | 2.50430351 |
| 12 | PRPF4B | 2.32335874 |
| 13 | TEC | 2.18850451 |
| 14 | STK16 | 2.16679721 |
| 15 | SMG1 | 2.11775864 |
| 16 | EPHB1 | 2.09670842 |
| 17 | TAOK1 | 2.07975661 |
| 18 | NME2 | 2.07224747 |
| 19 | FGR | 1.99609611 |
| 20 | DYRK3 | 1.97231678 |
| 21 | VRK1 | 1.94749679 |
| 22 | CDK12 | 1.90396379 |
| 23 | KSR2 | 1.84822761 |
| 24 | MAP3K3 | 1.84139759 |
| 25 | WEE1 | 1.81838771 |
| 26 | STK10 | 1.77478689 |
| 27 | BTK | 1.74453696 |
| 28 | MKNK2 | 1.71017557 |
| 29 | HCK | 1.69684598 |
| 30 | RPS6KA4 | 1.65331556 |
| 31 | CDK8 | 1.63654915 |
| 32 | GRK6 | 1.62796822 |
| 33 | PIM1 | 1.58738101 |
| 34 | PIM2 | 1.53654027 |
| 35 | MKNK1 | 1.52071460 |
| 36 | TRIB3 | 1.51312302 |
| 37 | CDK7 | 1.48518797 |
| 38 | ATR | 1.47985934 |
| 39 | MAP3K1 | 1.46681102 |
| 40 | CDK19 | 1.43394805 |
| 41 | RPS6KB2 | 1.41172839 |
| 42 | MAP3K12 | 1.40450975 |
| 43 | BRD4 | 1.40001236 |
| 44 | EIF2AK3 | 1.38504313 |
| 45 | JAK2 | 1.37088377 |
| 46 | ZAP70 | 1.35717159 |
| 47 | SRPK1 | 1.34482708 |
| 48 | BUB1 | 1.24022844 |
| 49 | SIK2 | 1.23381245 |
| 50 | ACVR1B | 1.21766781 |
| 51 | EIF2AK1 | 1.20121124 |
| 52 | CDK4 | 1.17454920 |
| 53 | PTK6 | 1.16876287 |
| 54 | NLK | 1.16250219 |
| 55 | PASK | 1.15686839 |
| 56 | IRAK4 | 1.14755404 |
| 57 | ITK | 1.13758400 |
| 58 | MAP3K13 | 1.13184477 |
| 59 | CLK1 | 1.13090531 |
| 60 | MAP3K11 | 1.10175133 |
| 61 | MAP2K3 | 1.08986160 |
| 62 | SYK | 1.08813714 |
| 63 | MARK2 | 1.08320116 |
| 64 | IKBKB | 1.02638938 |
| 65 | IRAK2 | 1.02127231 |
| 66 | TLK1 | 1.01936134 |
| 67 | YES1 | 0.99084141 |
| 68 | IKBKE | 0.98469483 |
| 69 | MAP3K2 | 0.95780818 |
| 70 | TSSK6 | 0.93226797 |
| 71 | PRKD2 | 0.93117953 |
| 72 | TBK1 | 0.93009791 |
| 73 | MAP3K14 | 0.92776789 |
| 74 | MST4 | 0.92307011 |
| 75 | TESK1 | 0.91567112 |
| 76 | STK4 | 0.91562119 |
| 77 | JAK3 | 0.91435773 |
| 78 | TAOK2 | 0.90449388 |
| 79 | IRAK1 | 0.88831407 |
| 80 | MARK3 | 0.86140154 |
| 81 | EIF2AK2 | 0.84894863 |
| 82 | MATK | 0.84220237 |
| 83 | BMX | 0.83532822 |
| 84 | CHEK2 | 0.81239050 |
| 85 | PDK1 | 0.80723832 |
| 86 | KIT | 0.79083432 |
| 87 | PDPK1 | 0.78226050 |
| 88 | TGFBR1 | 0.78175162 |
| 89 | AURKB | 0.78120903 |
| 90 | BRSK2 | 0.77794599 |
| 91 | RAF1 | 0.77625395 |
| 92 | TAOK3 | 0.77505267 |
| 93 | HIPK2 | 0.77334251 |
| 94 | PLK4 | 0.76335776 |
| 95 | JAK1 | 0.75920819 |
| 96 | FGFR4 | 0.75461173 |
| 97 | RPS6KA6 | 0.75339947 |
| 98 | CHUK | 0.73230695 |
| 99 | PLK1 | 0.72890026 |
| 100 | TYK2 | 0.72773219 |
| 101 | TESK2 | 0.72077470 |
| 102 | TTK | 0.72035722 |
| 103 | CDK6 | 0.70988583 |
| 104 | MAP3K6 | 0.70974369 |
| 105 | CHEK1 | 0.70124576 |
| 106 | RPS6KA5 | 0.69620774 |
| 107 | ALK | 0.69511883 |
| 108 | MAP3K8 | 0.68751769 |
| 109 | STK11 | 0.68305652 |
| 110 | ZAK | 0.68019994 |
| 111 | MAP2K4 | 0.67351371 |
| 112 | DYRK1B | 0.65530549 |
| 113 | TGFBR2 | 0.65477973 |
| 114 | LCK | 0.65332208 |
| 115 | RPS6KC1 | 0.64903667 |
| 116 | RPS6KL1 | 0.64903667 |
| 117 | ATM | 0.64842511 |
| 118 | FLT3 | 0.62948015 |
| 119 | PAK4 | 0.62489629 |
| 120 | CCNB1 | 0.62310877 |
| 121 | MAPK4 | 0.62084002 |
| 122 | KSR1 | 0.60897214 |
| 123 | MAP3K5 | 0.60830403 |
| 124 | TNIK | 0.59190701 |
| 125 | FYN | 0.58523558 |
| 126 | LYN | 0.58403241 |
| 127 | PRKG2 | 0.54702554 |
| 128 | CSF1R | 0.53315023 |
| 129 | SGK3 | 0.48444756 |
| 130 | CDK2 | 0.47914775 |
| 131 | SIK1 | 0.47012071 |
| 132 | MAP3K7 | 0.46554204 |
| 133 | MAP2K2 | 0.46512849 |
| 134 | MAPK11 | 0.46166816 |
| 135 | TNK2 | 0.45290403 |
| 136 | FGFR3 | 0.45260691 |
| 137 | RPS6KA1 | 0.45026397 |
| 138 | MAP2K6 | 0.44934470 |
| 139 | LRRK2 | 0.44134023 |
| 140 | MAPKAPK5 | 0.42438619 |
| 141 | RET | 0.42226335 |
| 142 | BLK | 0.41758435 |
| 143 | MAPKAPK2 | 0.41506714 |
| 144 | STK38 | 0.41494025 |
| 145 | CSNK2A2 | 0.40441781 |
| 146 | MAPK12 | 0.39906006 |
| 147 | PRKCQ | 0.34783278 |
| 148 | PRKCZ | 0.34601827 |
| 149 | CDC42BPA | 0.31182669 |
| 150 | PIK3CG | 0.29445655 |
| 151 | PKN2 | 0.26650645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.18354319 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.28818662 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.00407650 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.64905266 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.63313657 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56234258 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.53828189 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.52982815 |
| 9 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.21516808 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.21174495 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.05073274 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.91298097 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 1.85452623 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78877821 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.77027756 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73667683 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 1.72845642 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69774161 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66956446 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.59552062 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57013907 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.52581333 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.51898845 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51012075 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.44236146 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40873981 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39785603 |
| 28 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.36985312 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.34027117 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33538250 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30454564 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.29633937 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28426703 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22502554 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20619495 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20477601 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.19712538 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19011206 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18789887 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17276981 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17070574 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15678741 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13023912 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11719816 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09443075 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08602473 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08458424 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06534289 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05238490 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05071759 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04786266 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04770645 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02250622 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99110984 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.98942357 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.98422166 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.95879480 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95104662 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95090819 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93476187 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92421604 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89836269 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.89606088 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87869999 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.86433743 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 0.86193171 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83794369 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82052423 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81865695 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79534797 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78504809 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77079071 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75613969 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74087456 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.73708213 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72793863 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72195079 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71883553 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71259931 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70817937 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70665021 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69659392 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69073326 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68238607 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67540938 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66462465 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63769491 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63471705 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62406782 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60173415 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59575185 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.59383832 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59094527 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58247201 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58189311 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58118496 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.57256732 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.55460768 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54927525 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54920850 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54168323 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.53267704 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53071375 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52851923 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50646571 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50534909 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49950119 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49417118 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.49305019 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48939765 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48861838 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.48857088 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.48233709 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46371757 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46169316 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45712360 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44535059 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44467002 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44246100 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.44052312 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.42283629 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.42220458 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41916601 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41422768 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40999227 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40398932 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38672077 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37579331 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.36619348 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36177264 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.36099706 |
| 132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35456376 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34682886 |
| 134 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34477304 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34187332 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33168312 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32522056 |
| 138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31434791 |

